Cardiology
Heparin Induced Thrombocytopenia (HIT) Anti-Platelet Factor 4 (Heparin PF4H) IgG Quantitative Test
This test detects antibodies associated with Heparin Induced Thrombocytopenia (HIT), a serious reaction to heparin therapy. It measures anti-PF4 IgG antibodies to aid in diagnosing HIT and guiding treatment.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- 3 mL whole blood collected in a Blue Top (Sodium Citrate) tube. The sample must be mixed thoroughly by inversion.
- Results
- Confirm with the laboratory before booking.
- Preparation
- Overnight fasting is preferred. Ensure the Coagulation Requisition Form (Form 15) is completed.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Heparin Induced Thrombocytopenia (HIT) Anti-Platelet Factor 4 (Heparin PF4H) IgG Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients receiving heparin therapy who develop thrombocytopenia.
- ✓Patients with unexplained thrombosis after heparin exposure.
- ✓Patients with a history of HIT.
- ✓Patients with suspected HIT based on clinical presentation.
- ✓Monitoring patients with known HIT.
In plain language
What this test helps you understand
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Thrombotic Risk Screen Test
Assess your risk for thrombotic disorders like blood clots with the Thrombotic Risk Screen Test. This test evaluates key coagulation factors to help identify potential issues.
Learn more →ADAMTS13 Activity Test
The ADAMTS13 Activity Test measures the function of the ADAMTS13 enzyme, important for regulating blood clotting. It helps diagnose conditions like Thrombotic Thrombocytopenic Purpura (TTP).
Learn more →Antithrombin Activity Functional Test
Assess your risk for blood clotting disorders with the Antithrombin Activity Functional Test. This test measures antithrombin levels, crucial for regulating blood coagulation. Confirm with the laboratory before booking.
Learn more →Apolipoprotein A1 Apo A Test
The Apolipoprotein A1 (Apo A1) test measures the level of Apo A1 protein in your blood, a key indicator of cardiovascular health and lipid metabolism. This test helps assess your risk for heart disease.
Learn more →